Pipeline

ImmuPharma is a biopharmaceutical company that specialises in the usage and development of biopolymers, specifically peptides.

Our late-stage to preclinical pipeline is focused on two core therapeutic areas; autoimmunity & inflammation and anti-infectives.

Lupuzor™ Lupus
P140 CIDP*
P140 other indications

*Phase 2/3 adaptive trial becomes a pivotal trial for filing

BioAMB Fungal infections
BioCIN Bacterial infections

Our core therapeutic areas

The P140 platform
LUPUZORTM for Lupus
P140 for CIDP

BioAMB
for systemic fungal infections
BioCIN
for severe bacterial infections

Key progress